IL-17 Ligand
-
Crusekitug
0 ImagesCat. No.: HY-P991129CAS No.: 2956768-50-4Synonyms: QX-002NCrusekitug is a humanized monoclonal antibody targeting human interleukin 17A (IL-17A). Crusekitug specifically binds to IL-17A, blocking its signal transduction, thus exerting immunosuppressive and anti-inflammatory activities. Crusekitug is promising for research of autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis.
